These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new fluorescent probe for the equilibrative inhibitor-sensitive nucleoside transporter. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA)-chi 2-fluorescein. Wiley JS; Brocklebank AM; Snook MB; Jamieson GP; Sawyer WH; Craik JD; Cass CE; Robins MJ; McAdam DP; Paterson AR Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):667-72. PubMed ID: 1996965 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein. Gati WP; Paterson AR; Larratt LM; Turner AR; Belch AR Blood; 1997 Jul; 90(1):346-53. PubMed ID: 9207471 [TBL] [Abstract][Full Text] [Related]
5. Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression. Pressacco J; Mitrovski B; Erlichman C; Hedley DW Cancer Res; 1995 Apr; 55(7):1505-8. PubMed ID: 7882359 [TBL] [Abstract][Full Text] [Related]
6. Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC). Gati WP; Paterson AR; Belch AR; Chlumecky V; Larratt LM; Mant MJ; Turner AR Leuk Lymphoma; 1998 Dec; 32(1-2):45-54. PubMed ID: 10037000 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells. Elstein KH; Mole ML; Setzer RW; Zucker RM; Kavlock RJ; Rogers JM; Lau C Toxicol Appl Pharmacol; 1997 Sep; 146(1):29-39. PubMed ID: 9299594 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric studies of nucleoside transport regulation in single chromaffin cells. Sen RP; Delicado EG; Alvarez A; Brocklebank AM; Wiley JS; Miras-Portugal MT FEBS Lett; 1998 Feb; 422(3):368-72. PubMed ID: 9498818 [TBL] [Abstract][Full Text] [Related]
9. Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter. Wiley JS; Cebon JS; Jamieson GP; Szer J; Gibson J; Woodruff RK; McKendrick JJ; Sheridan WP; Biggs JC; Snook MB Leukemia; 1994 Jan; 8(1):181-5. PubMed ID: 8289485 [TBL] [Abstract][Full Text] [Related]
10. Deoxyribonucleoside triphosphates in human cells: changes in disease and following exposure to drugs. Tattersall MH; Lavoie A; Ganeshaguru K; Tripp E; Hoffbrand AV Eur J Clin Invest; 1975 Apr; 5(2):191-202. PubMed ID: 1149780 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content. Wright AM; Paterson AR; Sowa B; Akabutu JJ; Grundy PE; Gati WP Br J Haematol; 2002 Mar; 116(3):528-37. PubMed ID: 11849208 [TBL] [Abstract][Full Text] [Related]
12. Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Rauchwerger DR; Firby PS; Hedley DW; Moore MJ Cancer Res; 2000 Nov; 60(21):6075-9. PubMed ID: 11085530 [TBL] [Abstract][Full Text] [Related]
13. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), a novel ligand with high affinity for polypeptides associated with nucleoside transport. Partial purification of the nitrobenzylthioinosine-binding protein of pig erythrocytes by affinity chromatography. Agbanyo FR; Vijayalakshmi D; Craik JD; Gati WP; McAdam DP; Asakura J; Robins MJ; Paterson AR; Cass CE Biochem J; 1990 Sep; 270(3):605-14. PubMed ID: 2241896 [TBL] [Abstract][Full Text] [Related]
14. Characterization of equilibrative and concentrative Na+-dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells. Roovers KI; Meckling-Gill KA J Cell Physiol; 1996 Mar; 166(3):593-600. PubMed ID: 8600163 [TBL] [Abstract][Full Text] [Related]
15. Reduction of equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter in tamoxifen-treated MCF-7 cells: an oestrogen-reversible phenomenon. Goh LB; Lee CW Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):31-6. PubMed ID: 9355731 [TBL] [Abstract][Full Text] [Related]
16. Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles. Lum PY; Ngo LY; Bakken AH; Unadkat JD Cancer Chemother Pharmacol; 2000; 45(4):273-8. PubMed ID: 10755314 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and flow cytometric evaluation of novel 1,2,3,4-tetrahydroisoquinoline conformationally constrained analogues of nitrobenzylmercaptopurine riboside (NBMPR) designed for probing its conformation when bound to the es nucleoside transporter. Zhu Z; Furr J; Buolamwini JK J Med Chem; 2003 Feb; 46(5):831-7. PubMed ID: 12593662 [TBL] [Abstract][Full Text] [Related]
18. Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters. Hammond JR; Archer RG J Pharmacol Exp Ther; 2004 Mar; 308(3):1083-93. PubMed ID: 14634039 [TBL] [Abstract][Full Text] [Related]
19. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation. Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]